REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough leukemia: drug combo trial shows promise
Disease control CompletedThis study tested a drug called palbociclib combined with standard chemotherapy in children whose acute lymphoblastic leukemia had returned or did not respond to treatment. The main goal was to find a safe dose and understand side effects. Only 2 children took part, so results ar…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
New pill shows promise in early trial for tough blood cancers
Disease control CompletedThis early-phase study tested an experimental pill called LP-108, taken alone or with another drug (azacitidine), in 32 adults with blood cancers (MDS, CMML, or AML) that returned or didn't respond to prior therapy. The main goals were to find the safest dose and understand how t…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 22, 2026 13:51 UTC